Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ClaritevMPLNW 64 EV-to-OCF is 0.00 as of Aug. 11, 2026. GuruFocus rates MPLNW with a GF Score™ of 64/100. The stock has 6 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Claritev ranks worse than 92.22% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Claritev's Enterprise Value is $0.00 Mil.
Claritev's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $133.04 Mil. Therefore, Claritev's EV-to-OCF for today is 0.00.
The historical rank and industry rank for Claritev's EV-to-OCF or its related term are showing as below:
MPLNW'
s EV-to-OCF Range Over the Past 10 Years
Min: 13.73 Med: 27.65 Max: 491.38
Current: 51.57
During the past 8 years, the highest EV-to-OCF of Claritev was 491.38. The lowest was 13.73. And the median was 27.65.
MPLNW's EV-to-OCF is ranked worse than 92.22% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 8.95
vs MPLNW: 51.57
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Claritev's share price for today is $0.0001.
Claritev's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Claritev EV-to-OCF Related Terms
Claritev EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Claritev's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Claritev's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Claritev EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Claritev's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Claritev's EV-to-OCF falls into.
Claritev's current Enterprise Value is $0.00 Mil.
Claritev's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $133.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Claritev (MPLNW) has a EV-to-OCF of 0.00 as of Aug. 11, 2026. Over the past decade, Claritev's EV-to-OCF has ranged from 13.73 to 491.38. According to the industry distribution chart, Claritev ranks #628 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 92.2%.
Is Claritev's EV-to-OCF too high?
Claritev's current EV-to-OCF is 0.00. Over the past 10 years, this metric has ranged from a low of 13.73 to a high of 491.38. Based on the distribution chart, Claritev ranks #628 out of 681 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Claritev has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Claritev's EV-to-OCF compare to SLP and TBRG?
According to the Healthcare Providers & Services industry distribution chart, Claritev ranks #628 out of 681 companies for EV-to-OCF. This places Claritev in the lower half of its industry. The industry median EV-to-OCF is 8.95. Historically, Claritev's own EV-to-OCF has ranged from 13.73 to 491.38 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.95, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Claritev's current EV-to-OCF is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Claritev stock overvalued right now?
Claritev (MPLNW) has a current EV-to-OCF of 0.00. The current EV-to-OCF is 0.00. Claritev's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Claritev (MPLNW), the current EV-to-OCF is 0.00 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
64GF Score
Get the complete analysis for MPLNW
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MPLNW has been successfully added to your 
